Page last updated: 2024-09-03

mk 0663 and Peptic Ulcer

mk 0663 has been researched along with Peptic Ulcer in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (87.50)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, FY; Chen, TS; Hsiang, KW; Lee, KC; Lee, SD; Lin, HC; Lin, HY; Lu, CL; Luo, JC	1
Evans, JK; Harper, S; Hunt, RH; Lee, M; Oxenius, B; Quan, H; Watson, DJ; Yu, C	1
Bolognese, JA; Curtis, SP; Ramey, DR; Reicin, AS; Watson, DJ; Yu, C	1
Cannon, CP; Cryer, B; Curtis, SP; Kaur, A; Laine, L	1
Parashar, A	1
Einecke, D	1
Krüger, K	1
Hunt, RH; Yuan, Y	1

Reviews

3 review(s) available for mk 0663 and Peptic Ulcer

Article	Year
The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis. Current medical research and opinion, 2005, Volume: 21, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Etoricoxib; Gastrointestinal Hemorrhage; Gastrointestinal Tract; Humans; Incidence; Intestinal Perforation; Peptic Ulcer; Proportional Hazards Models; Pyridines; Randomized Controlled Trials as Topic; Sulfones	2005
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet (London, England), 2007, Feb-10, Volume: 369, Issue:9560 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Female; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Osteoarthritis; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Pyridines; Sulfones	2007
Global gastrointestinal safety profile of etoricoxib and lumiracoxib. Current pharmaceutical design, 2007, Volume: 13, Issue:22 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Interactions; Endoscopy, Gastrointestinal; Etoricoxib; Humans; Occult Blood; Patient Selection; Peptic Ulcer; Peptic Ulcer Hemorrhage; Pyridines; Risk Assessment; Risk Factors; Sulfones	2007

Trials

1 trial(s) available for mk 0663 and Peptic Ulcer

Article	Year
The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. The American journal of gastroenterology, 2003, Volume: 98, Issue:8 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Endoscopy; Etoricoxib; Female; Gastrointestinal Hemorrhage; Humans; Ibuprofen; Incidence; Isoenzymes; Male; Membrane Proteins; Meta-Analysis as Topic; Middle Aged; Peptic Ulcer; Peptic Ulcer Perforation; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfones; Treatment Outcome	2003

Article

Year

The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.

The American journal of gastroenterology, 2003, Volume: 98, Issue:8

Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Endoscopy; Etoricoxib; Female; Gastrointestinal Hemorrhage; Humans; Ibuprofen; Incidence; Isoenzymes; Male; Membrane Proteins; Meta-Analysis as Topic; Middle Aged; Peptic Ulcer; Peptic Ulcer Perforation; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfones; Treatment Outcome

2003

Other Studies

4 other study(ies) available for mk 0663 and Peptic Ulcer

Article	Year
Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan. Clinical therapeutics, 2010, Volume: 32, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cohort Studies; Cyclooxygenase 2 Inhibitors; Etoricoxib; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Incidence; Logistic Models; Male; Middle Aged; Multivariate Analysis; Peptic Ulcer; Prospective Studies; Pyrazoles; Pyridines; Risk Factors; Sulfonamides; Sulfones; Taiwan	2010
Gastrointestinal safety of NSAIDs versus COX-2 inhibitors. Lancet (London, England), 2007, Apr-21, Volume: 369, Issue:9570 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Pyridines; Sulfones	2007
[Coronary risks with NSAID and coxibs. The end of hysteria]. MMW Fortschritte der Medizin, 2006, Nov-30, Volume: 148, Issue:48 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Cause of Death; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Humans; Osteoarthritis; Peptic Ulcer; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic; Risk; Sulfones; Thrombosis	2006
[3 questions about gastrointestinal risk. Are coxibs here clearly better than NSAID?]]. MMW Fortschritte der Medizin, 2006, Nov-30, Volume: 148, Issue:48 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Humans; Osteoarthritis; Peptic Ulcer; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic; Risk; Sulfones	2006